Notes to the Consolidated Financial Statements
(Unaudited)
1. Nature of Operations and Basis of Presentation
S&P Global Inc. (together with its consolidated subsidiaries, "S&P Global," the “Company,” “we,” “us” or “our”) is a provider of credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets.
Our operations consist of six reportable segments: S&P Global Market Intelligence ("Market Intelligence"), S&P Global Ratings ("Ratings"), S&P Global Commodity Insights ("Commodity Insights"), S&P Global Mobility ("Mobility"), S&P Dow Jones Indices ("Indices") and S&P Global Engineering Solutions ("Engineering Solutions").
•Market Intelligence is a global provider of multi-asset-class data and analytics integrated with purpose-built workflow solutions.
•Ratings is an independent provider of credit ratings, research, and analytics, offering investors and other market participants information, ratings and benchmarks.
•Commodity Insights is the leading independent provider of information and benchmark prices for the commodity and energy markets.
•Mobility is a leading provider of solutions serving the full automotive value chain including vehicle manufacturers (OEMs), automotive suppliers, mobility service providers, retailers, consumers, and finance and insurance companies.
•Indices is a global index provider that maintains a wide variety of valuation and index benchmarks for investment advisors, wealth managers and institutional investors.
•Engineering Solutions is a leading provider of engineering standards and related technical knowledge.
On February 28, 2022, we completed the merger with IHS Markit Ltd. ("IHS Markit") by acquiring 100% of the IHS Markit common stock that was issued and outstanding as of the date of acquisition, and as a result, IHS Markit and its subsidiaries became wholly owned consolidated subsidiaries of S&P Global, and the consolidated financial statements as of and during the three months ended March 31, 2022 include the financial results of IHS Markit from the date of acquisition. The merger with IHS Markit, a world leader in critical information, analytics, and solutions for the major industries and markets that drive economies, brings together two world-class organizations with leading brands and capabilities across information services that will be uniquely positioned to serve, facilitate and power the markets of the future.
The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. Therefore, the financial statements included herein should be read in conjunction with the financial statements and notes included in our Form 10-K for the year ended December 31, 2021 (our “Form 10-K”). Certain prior-year amounts have been reclassified to conform with current presentation.
In the opinion of management, all normal recurring adjustments considered necessary for a fair statement of the results of the interim periods have been included. The operating results for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the full year.
On an ongoing basis, we evaluate our estimates and assumptions, including those related to revenue recognition, allowance for doubtful accounts, valuation of long-lived assets, goodwill and other intangible assets, pension plans, incentive compensation and stock-based compensation, income taxes, contingencies and redeemable noncontrolling interests. Since the date of our Form 10-K, there have been no material changes to our critical accounting policies and estimates.
Restricted Cash
Restricted cash included in our consolidated balance sheets was $2 million and $8 million as of March 31, 2022 and December 31, 2021, respectively. Restricted cash primarily consisted of cash required to be on deposit under contractual agreements in connection with certain acquisitions and dispositions.
Contract Assets
Contract assets include unbilled amounts from when the Company transfers service to a customer before a customer pays consideration or before payment is due. As of March 31, 2022 and December 31, 2021, contract assets were $66 million and $9 million, respectively, and are included in accounts receivable in our consolidated balance sheets.
Unearned Revenue
We record unearned revenue when cash payments are received in advance of our performance. The increase in the unearned revenue balance at March 31, 2022 compared to December 31, 2021 is primarily driven by cash payments received in advance of satisfying our performance obligations, partially offset by $835 million of revenues recognized that were included in the unearned revenue balance at the beginning of the period.
Remaining Performance Obligations
Remaining performance obligations represent the transaction price of contracts for work that has not yet been performed. As of March 31, 2022, the aggregate amount of the transaction price allocated to remaining performance obligations was $4.1 billion. We expect to recognize revenue on approximately half and three-quarters of the remaining performance obligations over the next 12 and 24 months, respectively, with the remainder recognized thereafter.
We do not disclose the value of unfulfilled performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts where revenue is a usage-based royalty promised in exchange for a license of intellectual property.
Costs to Obtain a Contract
We recognize an asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that the costs associated with certain sales commission programs are incremental to the costs to obtain contracts with customers and therefore meet the criteria to be capitalized. Total capitalized costs to obtain a contract were $124 million and $137 million as of March 31, 2022 and December 31, 2021, respectively, and are included in prepaid and other current assets and other non-current assets on our consolidated balance sheets. The capitalized asset will be amortized over a period consistent with the transfer to the customer of the goods or services to which the asset relates, calculated based on the customer term and the average life of the products and services underlying the contracts which has been determined to be approximately 5 years. The expense is recorded within selling and general expenses.
We expense sales commissions when incurred if the amortization period is one year or less. These costs are recorded within selling and general expenses.
Equity in Income on Unconsolidated Subsidiaries
The Company holds an investment in a 50/50 joint venture arrangement with shared control with CME Group that combined each of the company’s post-trade services into a new joint venture, OSTTRA. The joint venture provides trade processing and risk mitigation operations and incorporates CME’s optimization businesses (Traiana, TriOptima, and Reset) and the Company’s MarkitSERV business. The combination is intended to increase operating efficiencies of both the company’s business to more effectively service clients with enhanced platforms and services for OTC markets across interest rate, FX, equity, and credit asset classes.
Other Income, net
The components of other income, net for the three months ended March 31 are as follows:
| | | | | | | | | | | | | | | |
| | | |
| (in millions) | 2022 | | 2021 | | | | |
| Other components of net periodic benefit cost | $ | (4) | | | $ | (11) | | | | | |
| Net (gain) loss from investments | (45) | | | 4 | | | | | |
| Other income, net | $ | (49) | | | $ | (7) | | | | | |
2. Acquisitions and Divestitures
Acquisitions
2022
Merger with IHS Markit
On February 28, 2022, we completed the merger with IHS Markit by acquiring 100% of the IHS Markit common stock that was issued and outstanding as of the date of acquisition, and as a result, IHS Markit and its subsidiaries became wholly owned consolidated subsidiaries of S&P Global.
Upon completion of the merger with IHS Markit, IHS Markit stockholders received 113.8 million shares of S&P Global’s common stock, at an exchange ratio of 0.2838 S&P Global shares for each share of IHS Markit common stock, with cash paid in lieu of fractional shares. The Company also issued approximately 0.9 million replacement equity award shares for IHS Markit equity awards that were assumed pursuant to the merger agreement.
The preliminary estimated fair value of the consideration transferred for IHS Markit was approximately $43.5 billion as of the merger date, which consisted of the following:
| | | | | |
| (in millions, except for share and per share data) | February 28, 2022 |
| Number of shares IHS Markit issued and outstanding* | 400,988,207 | |
| Exchange ratio | 0.2838 |
| Number of S&P Global common stock transferred to IHS Markit stockholders | 113,800,453 | |
| Closing price per share of S&P Global common stock** | $ | 380.89 | |
| Fair value of S&P Global common stock transferred IHS Markit stockholders | $ | 43,345 | |
| Fair value of S&P Global replacement equity awards attributable to pre-combination service | $ | 191 | |
| Total equity consideration | $ | 43,536 | |
*Excludes 25,219,470 IHS Markit shares held by the Markit Group Holdings Limited Employee Benefit Trust ("EBT"). The shares held by the EBT were converted in the merger into S&P Global shares at the exchange ratio of 0.2838 and will continue to be held by the trustee in the EBT.
**Based on S&P Global's closing stock price on February 25, 2022.
Preliminary Allocation of Purchase Price
The merger with IHS Markit was accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805, Business Combinations (“ASC 805”). The purchase price was allocated to the assets acquired and liabilities assumed based on the estimated fair values at the date of acquisition. The excess of the purchase price over the fair value of the net assets acquired was allocated to goodwill, of which $699 million is expected to be deductible for tax purposes. Goodwill is primarily attributed to synergies from future expected economic benefits, including enhanced revenue growth from expanded capabilities and geographic presence as well as substantial cost savings from duplicative overhead, streamlined operations and enhanced operational efficiency. Goodwill associated with the merger has not yet been assigned to the Company’s reportable segments. The March 31, 2022 consolidated balance sheet includes the assets and liabilities of IHS Markit, which have been measured at fair value as of the acquisition date. The preliminary allocation of purchase price recorded for IHS Markit was as follows:
| | | | | |
| (in millions) | February 28, 2022 |
| Assets acquired | |
| Cash and cash equivalents | $ | 310 | |
| Accounts receivable, net | 968 | |
| Prepaid and other current assets | 244 | |
| Assets of a business held for sale | 1,519 | |
| Property and equipment | 122 | |
| Right of use assets | 234 | |
| Goodwill | 30,136 | |
| Other intangible assets | 20,002 | |
| Other non-current assets | 1,730 | |
| Total assets acquired | $ | 55,265 | |
| Liabilities assumed | |
| Account payable | $ | 174 | |
| Accrued compensation | 81 | |
| Short-term debt | 968 | |
| Unearned revenue | 1,053 | |
| Other current liabilities | 577 | |
| Liabilities of a business held for sale | 72 | |
| Long-term debt | 4,191 | |
| Lease liabilities - non-current | 227 | |
| Deferred tax liability - non-current | 4,330 | |
| Other non-current liabilities | 56 | |
| Total liabilities assumed | $ | 11,729 | |
| Total consideration transferred | $ | 43,536 | |
The above fair values of assets acquired and liabilities assumed are preliminary and are based on the information that was available as of the reporting date. The fair values of the assets acquired and liabilities assumed, including the identifiable assets acquired, have been preliminarily determined using the income and cost approaches, and are partially based on inputs that are unobservable. For intangible assets, these inputs include forecasted future cash flows, revenue growth rates, customer attrition rates and discount rates that require judgement and are subject to change. Differences between the preliminary estimates and final accounting will occur, and those differences could be material.
The Company believes that the information provides a reasonable basis for estimating the fair values of the acquired assets and assumed liabilities, but the potential for measurement period adjustments exists based on the Company’s continuing review of matters related to the acquisition. The Company expects to complete the purchase price allocation as soon as practicable, but no later than one year from the acquisition date.
Acquired Identifiable Intangible Assets
The following table sets forth the components of the identifiable intangible assets acquired and their estimated useful lives:
| | | | | | | | |
| (in millions) | Fair Value | Weighted Average Useful Lives |
| Customer relationships | $ | 14,552 | | 25 years |
| Trade names and trademarks | 1,542 | | 14 years |
| Developed technology | 1,150 | | 10 years |
| Databases | 2,758 | | 12 years |
| Total Identified Intangible Assets | $ | 20,002 | | 21 years |
Expected Amortization Expense
Expected amortization expense for intangible assets over the next five years for the years ended December 31 is as follows:
| | | | | | | | | | | | | | | | | |
| (in millions) | 2022 | 2023 | 2024 | 2025 | 2026 |
| Amortization expense | $ | 1,148 | | $ | 1,143 | | $ | 1,141 | | $ | 1,114 | | $ | 1,092 | |
Acquisition-Related Expenses
The Company incurred acquisition-related costs of $230 million and $49 million related to the IHS Markit merger for the three months ended March 31, 2022 and 2021, respectively. These costs were included in selling and general expenses within the Company’s consolidated statements of income for the three months ended March 31, 2022 and 2021, respectively.
Pro forma information
Since the acquisition date, the results of operations for IHS Markit of $432 million of revenue and $55 million of operating profit for the three months ended March 31, 2022, have been included within the accompanying consolidated statements of income.
The following unaudited supplemental pro forma combined financial information presents the Company’s results of operations for the three months ended March 31, 2022 and 2021 as if the acquisition of IHS Markit had occurred on January 1, 2021. The pro forma financial information is presented for comparative purposes only and is not necessarily indicative of the Company’s operating results that may have actually occurred had the acquisition of IHS Markit been completed on January 1, 2021. The pro forma results do not include any transaction costs, anticipated synergies or other expected benefits of the acquisition.
| | | | | | | | |
| Three months ended March 31 |
| (in millions) | 2022 | 2021 |
| Revenue | $ | 3,072 | | $ | 3,022 | |
Net Income1 | $ | 1,519 | | $ | 644 | |
1 The proforma net income excludes $362 million of one-time merger and transaction costs for the three months ended March 31, 2022.
The unaudited pro forma financial information reflects pro forma adjustments to present the combined pro forma results of operations as if the acquisition had occurred on January 1, 2021 to give effect to certain events the Company believes to be directly attributable to the acquisition.
2021
During the three months ended March 31, 2021, we did not complete any material acquisitions.
Divestitures
2022
As a condition of securing regulatory approval for the merger, S&P Global and IHS Markit agreed to divest of certain of their businesses. S&P Global’s divestitures include CUSIP Global Services, its Leveraged Commentary and Data (“LCD”) business and a related family of leveraged loan indices while the IHS Markit’s divestitures include Oil Price Information Services (“OPIS”); Coal, Metals and Mining; and PetroChem Wire businesses and its base chemicals business.
In March of 2022, we completed the previously announced sale of CUSIP Global Services ("CGS"), a business within our Market Intelligence segment, to FactSet Research Systems Inc. for a purchase price of $1.925 billion in cash, subject to customary adjustments. During the three months ended March 31, 2022, we recorded a pre-tax gain of $1.344 billion ($999 million after tax) in Gain on dispositions in the consolidated statements of income related to the sale of CGS.
In February 2022, we completed the previously announced sale of OPIS to News Corp for $1.150 billion in cash.
2021
During the three months ended March 31, 2021, we did not complete any dispositions.
During the three months ended March 31, 2021, we recorded a pre-tax gain of $2 million ($2 million after-tax) in Gain on dispositions in the consolidated statements of income related to the sale of Standard & Poor's Investment Advisory Services LLC ("SPIAS"), a business within our Market Intelligence segment, in July of 2019.
Assets and Liabilities Held for Sale
The components of assets and liabilities held for sale in the consolidated balance sheet consist of the following:
| | | | | | | | |
| (in millions) | March 31, | December 31, |
| 2022 1 | 2021 2 |
| Accounts Receivable, net | 26 | | $ | 59 | |
| Goodwill | 381 | | 255 | |
| Other assets | — | | 7 | |
| Assets of businesses held for sale | $ | 407 | | $ | 321 | |
| | |
| Accounts payable and accrued expenses | $ | — | | $ | 11 | |
| Unearned revenue | 66 | | 138 | |
| Liabilities of businesses held for sale | $ | 66 | | $ | 149 | |
1 Assets and liabilities held for sale as of March 31, 2022 relate to LCD and the base chemicals business.
2 Assets and liabilities held for sale as of December 31, 2021 relate to CGS and LCD.
The operating profit of our businesses that were disposed of or classified as held for sale for the three months ended March 31 is as follows: | | | | | | | | | | | | | | | |
| | | |
| (in millions) | 2022 | | 2021 | | | | |
Operating profit 3 | $ | 34 | | | $ | 42 | | | | | |
3 The operating profit presented includes the revenue and recurring direct expenses associated with businesses disposed of or held for sale. The three months ended March 31, 2022 and 2021 excludes pre-tax gains related to the sale CGS and SPIAS of $1.3 billion and $2 million, respectively.
3. Income Taxes
The effective income tax rate was 30.4% and 23.4% for the three months ended March 31, 2022 and March 31, 2021, respectively. The increase in the three months ended March 31, 2022 was primarily due to the tax charge on merger related divestitures and deal related non-deductible costs.
At the end of each interim period, we estimate the annual effective tax rate and apply that rate to our ordinary quarterly earnings. The tax expense or benefit related to significant unusual or infrequently occurring items that will be separately reported or reported net of their related tax effect, and are individually computed, is recognized in the interim period in which those items occur. In addition, the effect of changes in enacted tax laws or rates or tax status is recognized in the interim period in which the change occurs.
The Company is continuously subject to tax examinations in various jurisdictions. As of March 31, 2022 and December 31, 2021, the total amount of federal, state and local, and foreign unrecognized tax benefits was $191 million and $147 million, respectively, exclusive of interest and penalties. We recognize accrued interest and penalties related to unrecognized tax benefits in interest expense and operating-related expense, respectively. As of March 31, 2022 and December 31, 2021, we had $30 million and $24 million, respectively, of accrued interest and penalties associated with unrecognized tax benefits. Based on the current status of income tax audits, we believe that the total amount of unrecognized tax benefits may decrease by approximately $19 million in the next twelve months as a result of the resolution of local tax examinations.
4. Debt
A summary of short-term and long-term debt outstanding is as follows: | | | | | | | | | | | |
| (in millions) | March 31, 2022 | | December 31, 2021 |
5.0% Senior Notes, due 2022 1 | $ | 66 | | | $ | — | |
4.125% Senior Notes, due 2023 2 | 39 | | | — | |
3.625% Senior Notes, due 2024 3 | 48 | | | — | |
4.75% Senior Notes, due 2025 4 | 267 | | | — | |
4.0% Senior Notes, due 2025 5 | 283 | | | 696 | |
4.0% Senior Notes, due 2026 6 | 3 | | | — | |
2.95% Senior Notes, due 2027 7 | 496 | | | 496 | |
2.45% Senior Notes, due 2027 8 | 1,234 | | | — | |
4.75% Senior Notes, due 2028 9 | 834 | | | — | |
4.25% Senior Notes, due 2029 10 | 1,038 | | | — | |
2.5% Senior Notes, due 2029 11 | 496 | | | 496 | |
2.7% Sustainability-Linked Senior Notes, due 2029 12 | 1,231 | | | — | |
1.25% Senior Notes, due 2030 13 | 593 | | | 593 | |
2.90% Senior Notes, due 2032 14 | 1,469 | | | — | |
6.55% Senior Notes, due 2037 15 | 290 | | | 290 | |
4.5% Senior Notes, due 2048 16 | 273 | | | 273 | |
3.25% Senior Notes, due 2049 17 | 590 | | | 589 | |
3.70% Senior Notes, due 2052 18 | 974 | | | — | |
2.3% Senior Notes, due 2060 19 | 682 | | | 681 | |
3.9% Senior Notes, due 2062 20 | 486 | | | — | |
| | | |
| | | |
| | | |
| | | |
| Total debt | 11,392 | | | 4,114 | |
| Less: short-term debt including current maturities | 66 | | | — | |
| Long-term debt | $ | 11,326 | | | $ | 4,114 | |
1 Interest payments are due semiannually on May 1 and November 1.
2 Interest payments are due semiannually on February 1 and August 1.
3 Interest payments are due semiannually on May 1 and November 1.
4 Interest payments are due semiannually on February 15 and August 15.
5 Interest payments are due semiannually on June 15 and December 1, and as of March 31, 2022, the unamortized debt discount and issuance costs total $4 million.
6 Interest payments are due semiannually on March 1 and September 1.
7 Interest payments are due semiannually on January 22 and July 22, and as of March 31, 2022, the unamortized debt discount and issuance costs total $4 million.
8 Interest payments are due semiannually on March 1 and September 1, beginning on September 1, 2022, and as of March 31, 2022, the unamortized debt discount and issuance costs total $16 million.
9 Interest payments are due semiannually on February 1 and August 1.
10 Interest payments are due semiannually on May 1 and November 1.
11 Interest payments are due semiannually on June 1 and December 1, and as of March 31, 2022, the unamortized debt discount and issuance costs total $4 million.
12 Interest payments are due semiannually on March 1 and September 1, beginning on September 1, 2022, and as of March 31, 2022, the unamortized debt discount and issuance costs total $19 million.
13 Interest payments are due semiannually on February 15 and August 15, and as of March 31, 2022, the unamortized debt discount and issuance costs total $7 million.
14 Interest payments are due semiannually on March 1 and September 1, beginning on September 1, 2022, and as of March 31, 2022, the unamortized debt discount and issuance costs total $31 million.
15 Interest payments are due semiannually on May 15 and November 15, and as of March 31, 2022, the unamortized debt discount and issuance costs total $3 million.
16 Interest payments are due semiannually on May 15 and November 15, and as of March 31, 2022, the unamortized debt discount and issuance costs total $10 million.
17 Interest payments are due semiannually on June 1 and December 1, and as of March 31, 2022, the unamortized debt discount and issuance costs total $10 million.
18 Interest payments are due semiannually on March 1 and September 1, beginning on September 1, 2022, and as of March 31, 2022, the unamortized debt discount and issuance costs total $26 million.
19 Interest payments are due semiannually on February 15 and August 15, and as of March 31, 2022, the unamortized debt discount and issuance costs total $18 million.
20 Interest payments are due semiannually on March 1 and September 1, beginning on September 1, 2022, and as of March 31, 2022, the unamortized debt discount and issuance costs total $14 million.
The fair value of our total debt borrowings was $10.8 billion and $4.4 billion as of March 31, 2022 and December 31, 2021, respectively, and was estimated based on quoted market prices.
On February 28, 2022, we completed the merger with IHS Markit in an all-stock transaction. In the transaction, we assumed IHS Markit's publicly traded debt, with an outstanding principal balance of $4.6 billion, which was recorded at fair value of $4.9 billion on the acquisition date. Debt assumed consisted of the following:
•5.00% Senior Notes due November 1, 2022 with an outstanding principal balance of $748 million.
•4.125% Senior Notes due August 1, 2023 with an outstanding principal balance of $500 million.
•3.625% Senior Notes due May 1, 2024 with an outstanding principal balance of $400 million.
•4.75% Senior Notes due February 15, 2025 with an outstanding principal balance of $800 million.
•4.00% Senior Notes due March 1, 2026 with an outstanding principal balance of $500 million.
•4.75% Senior Notes due August 1, 2028 with an outstanding principal balance of $750 million.
•4.25% Senior Notes due May 1, 2029 with an outstanding principal balance of $950 million.
The adjustment to fair value of the Senior Notes of approximately $292 million on the acquisition date will be amortized as an adjustment to interest expense over the remaining contractual terms of the Senior Notes.
On March 2, 2022, we completed the offer (the "Exchange Offer") to exchange outstanding notes issued by IHS Markit for new notes issued by us and fully and unconditionally guaranteed by Standard & Poor's Financial Services LLC with the same interest rate, interest payment dates, maturity date and redemption terms as each corresponding series of exchange IHS Markit notes and cash. Of the approximately $4.6 billion in aggregate principal amount of IHS Markit's Senior Notes offered in the exchange, 96% percent, or approximately $4.5 billion, were tendered and accepted. The portion not exchanged, approximately $175 million, remains outstanding across seven series of Senior Notes issued by IHS Markit. The Exchange Offer was treated as a debt modification for accounting purposes resulting in a portion of the unamortized fair value adjustment of the IHS Markit Senior Notes allocated to the new debt issued by S&P Global on the settlement date of the exchange. See Note 2 — Acquisitions and Divestitures for additional information on the merger.
On March 4, 2022, we issued $1,250 million of 2.45% Senior Notes due 2027, $1,250 million of 2.7% Sustainability-Linked Senior Notes due 2029, $1,500 million of 2.9% Senior Notes due 2032, $1,000 million of 3.7% Senior Notes due 2052, and $500 million of 3.9% Senior Notes due 2062. The Notes are fully and unconditionally guaranteed by our wholly-owned subsidiary, Standard & Poor's Financial Services LLC. In the first quarter of 2022, we used a portion of the net proceeds from the new debt issuance to fund the redemption and extinguishment of the outstanding principal amount of our 4.125% Senior Notes due 2023, 3.625% Senior Notes due 2024, and our 4.0% Senior Notes due 2026 which were former IHS Markit Notes that were exchanged to SPGI Notes as part of the Exchange Offer. In addition, we also used part of the net proceeds from the new debt issuance noted above to fund the early tender as well as a subsequent full redemption of our 5.0% Senior Notes due 2022 and the 4.750% Senior Notes due 2025, both of which were former IHS Markit Notes that were exchanged to SPGI Notes as part of the Exchange Offer, as well as our 4.0% Senior Notes due 2025. The majority of the liability management transactions settled within the first quarter, however, given the timing of certain redemptions a lesser portion of these settled post-quarter end.
During the three months ended March 31, 2022, we recognized a $17 million loss on extinguishment of debt which includes a $118 million tender premium paid to tendering note holders in accordance with the terms of the tender offer, offset by a $101 million non-cash write-off related to the fair market value step up premium on extinguished debt.
We have the ability to borrow a total of $2.0 billion through our commercial paper program, which is supported by our $2.0 billion five-year credit agreement (our "credit facility") that will terminate on April 26, 2026. On April 26, 2021, we entered into a revolving $1.5 billion five-year credit agreement that included an accordion feature which allowed the Company to increase the total commitments thereunder by up to an additional $500 million, subject to certain customary terms and conditions. On February 25, 2022, we exercised the accordion feature which increased the total commitments available under our credit facility from $1.5 billion to $2.0 billion. As of March 31, 2022 and December 31, 2021, there was no commercial paper outstanding.
Commitment fees for the unutilized commitments under the credit facility and applicable margins for borrowings thereunder are linked to the Company achieving three environmental sustainability performance indicators related to emissions, tested annually. We currently pay a commitment fee of 9 basis points. The credit facility contains customary affirmative and negative covenants and customary events of default. The occurrence of an event of default could result in an acceleration of the obligations under the credit facility.
The only financial covenant required is that our indebtedness to cash flow ratio, as defined in our credit facility, was not greater than 4 to 1, and this covenant level has never been exceeded.
5. Derivative Instruments
Our exposure to market risk includes changes in foreign exchange rates and interest rates. We have operations in foreign countries where the functional currency is primarily the local currency. For international operations that are determined to be extensions of the parent company, the U.S. dollar is the functional currency. We typically have naturally hedged positions in most countries from a local currency perspective with offsetting assets and liabilities. As of March 31, 2022 and December 31, 2021, we have entered into foreign exchange forward contracts to mitigate or hedge the effect of adverse fluctuations in foreign exchange rates and cross currency swap contracts to hedge a portion of our net investment in a foreign subsidiary against volatility in foreign exchange rates. During the three months ended March 31, 2022, we entered into a series of interest rate swaps to mitigate or hedge the adverse fluctuations in interest rates on our future debt refinancing. These contracts are recorded at fair value that is based on foreign currency exchange rates and interest rates in active markets; therefore, we classify these derivative contracts within Level 2 of the fair value hierarchy. We do not enter into any derivative financial instruments for speculative purposes.
Undesignated Derivative Instruments
During the three months ended March 31, 2022 and twelve months ended December 31, 2021, we entered into foreign exchange forward contracts in order to mitigate the change in fair value of specific assets and liabilities in the consolidated balance sheet. These forward contracts do not qualify for hedge accounting. As of March 31, 2022 and December 31, 2021, the aggregate notional value of these outstanding forward contracts was $878 million and $376 million, respectively. The changes in fair value of these forward contracts are recorded in prepaid and other assets or other current liabilities in the consolidated balance sheet with their corresponding change in fair value recognized in selling and general expenses in the consolidated statement of income. The amount recorded in prepaid and other current assets as of March 31, 2022 and December 31, 2021 was $5 million and $5 million, respectively. The amount recorded in other current liabilities as of March 31, 2022 and December 31, 2021 was $3 million and less than $1 million, respectively. The amount recorded in selling and general expense related to these contracts was a net loss of $19 million and $6 million for three months ended March 31, 2022 and 2021 respectively.
Net Investment Hedges
During the twelve months ended December 31, 2021, we entered into cross currency swaps to hedge a portion of our net investment in one of our European subsidiaries against volatility in the Euro/U.S. dollar exchange rate. These swaps are designated and qualify as a hedge of a net investment in a foreign subsidiary and are scheduled to mature in 2024, 2029, 2030. As of March 31, 2022 and December 31, 2021, the notional value of our outstanding cross currency swaps designated as a net investment hedge was $1 billion. The changes in the fair value of swaps are recognized in foreign currency translation
adjustments, a component of other comprehensive income (loss), and reported in accumulated other comprehensive loss in our consolidated balance sheet. The gain or loss will be subsequently reclassified into net earnings when the hedged net investment is either sold or substantially liquidated. We have elected to assess the effectiveness of our net investment hedges based on changes in spot exchange rates. Accordingly, amounts related to the cross currency swaps recognized directly in net income for the three months ended March 31, 2022 represent net periodic interest settlements and accruals, which are recognized in interest expense, net. We recognized net interest expense of $10 million for the three months ended March 31, 2022 and net interest income of $5 million for the three months ended March 31, 2021, respectively.
Cash Flow Hedges
Foreign Exchange Forward Contracts
During the three months ended March 31, 2022 and twelve months ended December 31, 2021, we entered into a series of foreign exchange forward contracts to hedge a portion of the Indian rupee, British pound, and Euro exposures through the first quarter of 2024 and the fourth quarter of 2023, respectively. These contracts are intended to offset the impact of movement of exchange rates on future revenue and operating costs and are scheduled to mature within twenty-four months. The changes in the fair value of these contracts are initially reported in accumulated other comprehensive loss in our consolidated balance sheet and are subsequently reclassified into revenue and selling and general expenses in the same period that the hedged transaction affects earnings.
As of March 31, 2022, we estimate that less than $1 million of pre-tax gain related to foreign exchange forward contracts designated as cash flow hedges recorded in other comprehensive income is expected to be reclassified into earnings within the next twelve months.
As of March 31, 2022 and December 31, 2021, the aggregate notional value of our outstanding foreign exchange forward contracts designated as cash flow hedges was $501 million and $498 million, respectively.
Interest Rate Swaps
During the the twelve months ended December 31, 2021, we entered into a series of interest rate swaps. These contracts are intended to mitigate or hedge the adverse fluctuations in interest rates on our future debt refinancing and are scheduled to mature beginning in the first quarter of 2027. These interest rate swaps are designated as cash flow hedges. The changes in the fair value of these contracts are initially reported in accumulated other comprehensive loss in our consolidated balance sheet and will be subsequently reclassified into interest expense, net in the same period that the hedged transaction affects earnings.
As of March 31, 2022, the aggregate notional value of our outstanding interest rate swaps designated as cash flow hedges was $1.4 billion.
The following table provides information on the location and fair value amounts of our cash flow hedges and net investment hedges as of March 31, 2022 and December 31, 2021: | | | | | | | | | | | | | | |
| (in millions) | | March 31, | | December 31, |
| Balance Sheet Location | | 2022 | | 2021 |
| Derivatives designated as cash flow hedges: | | | | |
| Prepaid and other current assets | Foreign exchange forward contracts | $ | 6 | | | $ | 7 | |
| | | | |
| Other current liabilities | Foreign exchange forward contracts | $ | 5 | | | $ | — | |
| Other non-current liabilities | Interest rate swap contracts | $ | 72 | | | $ | 270 | |
| Derivatives designated as net investment hedges: | | | | |
| | | | |
| Other non-current liabilities | Cross currency swaps | $ | 4 | | | $ | 17 | |
The following table provides information on the location and amounts of pre-tax gains (losses) on our cash flow hedges and net investment hedges for the three months ended March 31:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Gain (Loss) recognized in Accumulated Other Comprehensive Loss (effective portion) | | Location of Gain (Loss) reclassified from Accumulated Other Comprehensive Loss into Income (effective portion) | | Gain (Loss) reclassified from Accumulated Other Comprehensive Loss into Income (effective portion) |
| 2022 | | 2021 | | | | 2022 | | 2021 |
| Cash flow hedges - designated as hedging instruments | | | | | | | | | |
| Foreign exchange forward contracts | $ | (7) | | | $ | — | | | Revenue, Selling and general expenses | | $ | 2 | | | $ | 5 | |
| Interest rate swap contracts | $ | 113 | | | $ | 2 | | | Interest expense, net | | $ | — | | | $ | — | |
| | | | | | | | | |
| Net investment hedges - designated as hedging instruments | | | | | | | | | |
| Cross currency swaps | $ | 21 | | | $ | 15 | | | Interest expense, net | | $ | (1) | | | $ | — | |
| | | | | | | | | |
The activity related to the change in unrealized gains (losses) in accumulated other comprehensive loss was as follows for the three months ended March 31:
| | | | | | | | | | | | | | | |
| | | |
| (in millions) | 2022 | | 2021 | | | | |
| Cash Flow Hedges | | | | | | | |
| Foreign exchange forward contracts | | | | | | | |
| Net unrealized gains on cash flow hedges, net of taxes, beginning of period | $ | 6 | | | $ | 14 | | | | | |
| Change in fair value, net of tax | (3) | | | 5 | | | | | |
| Reclassification into earnings, net of tax | (2) | | | (5) | | | | | |
| Net unrealized gains on cash flow hedges, net of taxes, end of period | $ | 1 | | | $ | 14 | | | | | |
| | | | | | | |
| Interest rate swap contracts | | | | | | | |
| Net unrealized losses on cash flow hedges, net of taxes, beginning of period | $ | (203) | | | $ | — | | | | | |
| Change in fair value, net of tax | 85 | | | 2 | | | | | |
| Reclassification into earnings, net of tax | — | | | — | | | | | |
| Net unrealized (losses) gains on cash flow hedges, net of taxes, end of period | $ | (118) | | | $ | 2 | | | | | |
| | | | | | | |
| Net Investment Hedges | | | | | | | |
| Net unrealized losses on net investment hedges, net of taxes, beginning of period | $ | (17) | | | $ | (81) | | | | | |
| Change in fair value, net of tax | 14 | | | 11 | | | | | |
| Reclassification into earnings, net of tax | 1 | | | — | | | | | |
| Net unrealized losses on net investment hedges, net of taxes, end of period | $ | (2) | | | $ | (70) | | | | | |
6. Employee Benefits
We maintain a number of active defined contribution retirement plans for our employees. The majority of our defined benefit plans are frozen. As a result, no new employees will be permitted to enter these plans and no additional benefits for current participants in the frozen plans will be accrued.
We also have supplemental benefit plans providing senior management with supplemental retirement, disability and death benefits. Certain supplemental retirement benefits are based on final monthly earnings. In addition, we sponsor a voluntary 401(k) plan under which we may match employee contributions up to certain levels of compensation as well as profit-sharing plans under which we contribute a percentage of eligible employees' compensation to the employees' accounts.
We also provide certain medical, dental and life insurance benefits for active and retired employees and eligible dependents. The medical and dental plans and supplemental life insurance plan are contributory, while the basic life insurance plan is noncontributory. We currently do not prefund any of these plans.
We recognize the funded status of our retirement and postretirement plans in the consolidated balance sheets, with a corresponding adjustment to accumulated other comprehensive loss, net of taxes. The amounts in accumulated other comprehensive loss represent net unrecognized actuarial losses and unrecognized prior service costs. These amounts will be subsequently recognized as net periodic pension cost pursuant to our accounting policy for amortizing such amounts.
Net periodic benefit cost for our retirement and postretirement plans other than the service cost component are included in other income, net in our consolidated statements of income.
The components of net periodic benefit cost for our retirement plans and postretirement plans for the three months ended March 31 are as follows:
| | | | | | | | | | | | | | | |
| | | |
| (in millions) | 2022 | | 2021 | | | | |
| Service cost | $ | 1 | | | $ | 1 | | | | | |
| Interest cost | 12 | | | 10 | | | | | |
| Expected return on assets | (22) | | | (26) | | | | | |
| Amortization of prior service credit / actuarial loss | 3 | | | 4 | | | | | |
| Net periodic benefit cost | $ | (6) | | | $ | (11) | | | | | |
| | | | | | | |
| | | | | | | |
Net periodic benefit cost related to our postretirement plans reflected in the table above was not material for the three months ended March 31, 2022 and 2021.
As discussed in our Form 10-K, we changed certain discount rate assumptions for our retirement and postretirement plans and our expected return on assets assumption for our retirement plans which became effective on January 1, 2022. The effect of the assumption changes on retirement and postretirement expense for the three months ended March 31, 2022 did not have a material impact to our financial position, results of operations or cash flows.
In the first three months of 2022, we contributed $3 million to our retirement plans and expect to make additional required contributions of approximately $9 million to our retirement plans during the remainder of the year. We may elect to make additional non-required contributions depending on investment performance or any potential deterioration of our pension plan status in the remaining nine months of 2022.
7. Stock-Based Compensation
We issue stock-based incentive awards to our eligible employees under the 2019 Stock Incentive Plan ("2019 Plan") and to our eligible non-employee Directors under a Director Deferred Stock Ownership Plan. The 2019 Plan permits the granting of incentive stock options, nonqualified stock options, stock appreciation rights, performance stock, restricted stock and other stock-based awards.
For the three months ended March 31, 2022 and 2021, total stock-based compensation expense primarily related to restricted stock and unit awards was $94 million and $19 million, respectively. For the three months ended March 31, 2022, stock-based compensation expense primarily related to the early vesting of IHS Markit equity awards as a result of employee terminations and restructuring efforts. During the three month ended March 31, 2022, the Company granted 0.6 million shares of restricted stock and unit awards, which had a weighted average grant date fair value of $390.58 per share. Total unrecognized compensation expense related to unvested restricted stock and unit awards as of March 31, 2022 was $422 million, which is expected to be recognized over a weighted average period of 2.2 years.
8. Equity
Dividends
On January 26, 2022, the Board of Directors approved a quarterly common stock dividend of $0.77 per share.
On February 28, 2022, the Board of Directors approved a quarterly common stock dividend of $0.85 per share. The quarterly dividend will increase from $0.77 to $0.85 per share in the second quarter.
Stock Repurchases
On January 29, 2020, the Board of Directors approved a share repurchase program authorizing the purchase of 30 million shares (the "2020 Repurchase Program"), which was approximately 12% of the total shares of our outstanding common stock at that time. On December 4, 2013, the Board of Directors approved a share repurchase program authorizing the purchase of 50 million shares (the "2013 Repurchase Program"), which was approximately 18% of the total shares of our outstanding common stock at that time.
Our purchased shares may be used for general corporate purposes, including the issuance of shares for stock compensation plans and to offset the dilutive effect of the exercise of employee stock options. As of March 31, 2022, we completed the 2013 repurchase program and 15.5 million shares remained available under the 2020 Repurchase Program. Our 2020 Repurchase Program has no expiration date and purchases under this program may be made from time to time on the open market and in private transactions, depending on market conditions.
We enter into accelerated share repurchase (“ASR”) agreements with financial institutions to initiate share repurchases of our common stock. Under an ASR agreement, we pay a specified amount to the financial institution and receive an initial delivery of shares. This initial delivery of shares represents the minimum number of shares that we may receive under the agreement. Upon settlement of the ASR agreement, the financial institution delivers additional shares. The total number of shares ultimately delivered, and therefore the average price paid per share, is determined at the end of the applicable purchase period of each ASR agreement based on the volume weighted-average share price, less a discount. We account for our ASR agreements as two transactions: a stock purchase transaction and a forward stock purchase contract. The shares delivered under the ASR agreements resulted in a reduction of outstanding shares used to determine our weighted average common shares outstanding for purposes of calculating basic and diluted earnings per share. The repurchased shares are held in Treasury. The forward stock purchase contracts were classified as equity instruments.
During the three months ended March 31, 2022, we initiated a series of three identical uncapped ASR agreements aggregating a total of $7 billion as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions, except average price) | | | | | | | | | | | | |
| ASR Agreement Initiation Date | | | | Initial Shares Delivered | | Additional Shares Delivered | | Total Number of Shares Purchased | | Average Price Paid Per Share | | Total Cash Utilized |
| | | | | | | | | | | | |
March 1, 2022 1 | | | | 15.2 | | — | | | 15.2 | | $ | 390.58 | | | $ | 7,000 | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
1 The ASR agreement was structured as an uncapped ASR agreement in which we paid $7 billion and received an initial delivery of 15.2 million shares, representing 85% of the $7 billion at a price equal to the then market price of the Company. The final settlement of the transaction under the ASR is expected to be completed no later than the third quarter of 2022. The ASR agreement was executed under our 2020 Repurchase Program.
During the three months ended March 31, 2022, we purchased a total of 15.2 million shares for $7.0 billion of cash. During the three months ended March 31, 2021, we did not use cash to repurchase shares.
Redeemable Noncontrolling Interests
The agreement with the minority partners that own 27% of our S&P Dow Jones Indices LLC joint venture contains redemption features whereby interests held by minority partners are redeemable either (i) at the option of the holder or (ii) upon the occurrence of an event that is not solely within our control. Specifically, under the terms of the operating agreement of S&P Dow Jones Indices LLC, CME Group and CME Group Index Services LLC ("CGIS") has the right at any time to sell, and we are obligated to buy, at least 20% of their share in S&P Dow Jones Indices LLC. In addition, in the event there is a change of
control of the Company, for the 15 days following a change in control, CME Group and CGIS will have the right to put their interest to us at the then fair value of CME Group's and CGIS' minority interest.
If interests were to be redeemed under this agreement, we would generally be required to purchase the interest at fair value on the date of redemption. This interest is presented on the consolidated balance sheets outside of equity under the caption “Redeemable noncontrolling interest” with an initial value based on fair value for the portion attributable to the net assets we acquired, and based on our historical cost for the portion attributable to our S&P Index business. We adjust the redeemable noncontrolling interest each reporting period to its estimated redemption value, but never less than its initial fair value, using both income and market valuation approaches. Our income and market valuation approaches incorporate Level 3 fair value measures for instances when observable inputs are not available. The more significant judgmental assumptions used to estimate the value of the S&P Dow Jones Indices LLC joint venture include an estimated discount rate, a range of assumptions that form the basis of the expected future net cash flows (e.g., the revenue growth rates and operating margins), and a company specific beta. The significant judgmental assumptions used that incorporate market data, including the relative weighting of market observable information and the comparability of that information in our valuation models, are forward-looking and could be affected by future economic and market conditions. Any adjustments to the redemption value will impact retained income.
Noncontrolling interests that do not contain such redemption features are presented in equity.
Changes to redeemable noncontrolling interest during the three months ended March 31, 2022 were as follows:
| | | | | |
| (in millions) | |
| Balance as of December 31, 2021 | $ | 3,429 | |
| Net income attributable to redeemable noncontrolling interest | 59 | |
| |
| Distributions payable to redeemable noncontrolling interest | (60) | |
| Redemption value adjustment | 1 | |
| |
Balance as of March 31, 2022 | $ | 3,429 | |
Accumulated Other Comprehensive Loss
The following table summarizes the changes in the components of accumulated other comprehensive loss for the three months ended March 31, 2022:
| | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Foreign Currency Translation Adjustments | | Pension and Postretirement Benefit Plans | | Unrealized Gain (Loss) on Cash Flow Hedges | | | | Accumulated Other Comprehensive Loss |
| Balance as of December 31, 2021 | $ | (336) | | | $ | (305) | | | $ | (200) | | | | | $ | (841) | |
Other comprehensive (loss) income before reclassifications | (26) | | 1 | 5 | | | 82 | | | | | 61 | |
Reclassifications from accumulated other comprehensive income (loss) to net earnings | — | | | (1) | | 2 | (1) | | 3 | | | (2) | |
| Net other comprehensive (loss) income | (26) | | | 4 | | | 81 | | | | | 59 | |
| | | | | | | | | |
Balance as of March 31, 2022 | $ | (362) | | | $ | (301) | | | $ | (119) | | | | | $ | (782) | |
1Includes an unrealized gain related to our cross currency swaps. See note 5 – Derivative Instruments for additional detail of items recognized in accumulated other comprehensive loss.
2Reflects amortization of net actuarial losses and is net of a tax benefit of $1 million for the three months ended March 31, 2022. See Note 6 — Employee Benefits for additional details of items reclassed from accumulated other comprehensive loss to net earnings.
3See Note 5 — Derivative Instruments for additional details of items reclassified from accumulated other comprehensive loss to net earnings.
9. Earnings Per Share
Basic earnings per common share (“EPS”) is computed by dividing net income attributable to the common shareholders of the Company by the weighted-average number of common shares outstanding. Diluted EPS is computed in the same manner as basic EPS, except the number of shares is increased to include additional common shares that would have been outstanding if potential common shares with a dilutive effect had been issued. Potential common shares consist primarily of stock options and restricted performance shares calculated using the treasury stock method.
The calculation of basic and diluted EPS for the three months ended March 31 is as follows: | | | | | | | | | | | | | | | |
| | | |
| (in millions, except per share amounts) | 2022 | | 2021 | | | | |
Amounts attributable to S&P Global Inc. common shareholders: | | | | | | | |
| | | | | | | |
| | | | | | | |
| Net income | $ | 1,235 | | | $ | 755 | | | | | |
| | | | | | | |
Basic weighted-average number of common shares outstanding | 275.2 | | | 240.6 | | | | | |
| Effect of stock options and other dilutive securities | 1.1 | | | 1.0 | | | | | |
Diluted weighted-average number of common shares outstanding | 276.3 | | | 241.6 | | | | | |
| | | | | | | |
Earnings per share attributable to S&P Global Inc. common shareholders: | | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| Net income: | | | | | | | |
| Basic | $ | 4.49 | | | $ | 3.14 | | | | | |
| Diluted | $ | 4.47 | | | $ | 3.12 | | | | | |
We have certain stock options and restricted performance shares that are potentially excluded from the computation of diluted EPS. The effect of the potential exercise of stock options is excluded when the average market price of our common stock is lower than the exercise price of the related option during the period or when a net loss exists because the effect would have been antidilutive. Additionally, restricted performance shares are excluded because the necessary vesting conditions had not been met or when a net loss exists. For the three months ended March 31, 2022 and 2021, there were no stock options excluded. Restricted performance shares outstanding of 0.7 million and 0.4 million as of March 31, 2022 and 2021, respectively, were excluded.
10. Restructuring
We continuously evaluate our cost structure to identify cost savings associated with streamlining our management structure. Our 2022 and 2021 restructuring plan consisted of a company-wide workforce reduction of approximately 140 and 30 positions, and is further detailed below. The charges for the restructuring plans are classified as selling and general expenses within the consolidated statements of income and the reserves are included in other current liabilities in the consolidated balance sheets.
In certain circumstances, reserves are no longer needed because employees previously identified for separation resigned from the Company and did not receive severance or were reassigned due to circumstances not foreseen when the original plans were initiated. In these cases, we reverse reserves through the consolidated statements of income during the period when it is determined they are no longer needed.
The initial restructuring charge recorded and the ending reserve balance as of March 31, 2022 by segment is as follows: | | | | | | | | | | | | | | | | | | | | | | | |
| 2022 Restructuring Plan | | 2021 Restructuring Plan |
| (in millions) | Initial Charge Recorded | | Ending Reserve Balance | | Initial Charge Recorded | | Ending Reserve Balance |
| Market Intelligence | 18 | | | 18 | | | 3 | | | 3 | |
| Ratings | $ | 5 | | | $ | 3 | | | $ | 3 | | | $ | 3 | |
| Commodity Insights | 5 | | | 4 | | | — | | | — | |
| | | | | | | |
| Indices | 2 | | | 2 | | | — | | | — | |
| | | | | | | |
| Corporate | 44 | | | 44 | | | 13 | | | 13 | |
| Total | $ | 74 | | | $ | 71 | | | $ | 19 | | | $ | 19 | |
We recorded a pre-tax restructuring charge of $74 million primarily related to employee severance charges for the 2022 restructuring plan during the three months ended March 31, 2022 and have reduced the reserve by $3 million. The ending reserve balance for the 2021 restructuring plan was $19 million as of December 31, 2021. The reductions primarily related to cash payments for employee severance charges. For the three months ended March 31, 2022, we have made no reductions to the reserve for the 2021 restructuring plan.
11. Segment and Related Information
During the quarter ended March 31, 2022, following the completion of our merger with IHS Markit, we reorganized our reportable segments increasing from four reportable segments to six reportable segments: Market Intelligence, Ratings, Commodity Insights, Mobility, Indices and Engineering Solutions. Our Chief Executive Officer is our chief operating decision-maker and evaluates performance of our segments and allocates resources based primarily on operating profit. Segment operating profit does not include Corporate Unallocated expense, other income, net, interest expense, net, or loss on extinguishment of debt, net, as these are amounts that do not affect the operating results of our reportable segments. The creation of the two additional segments in 2022 did not materially impact prior years’ reportable segments.
A summary of operating results for the three months ended March 31 is as follows:
| | | | | | | | | | | | | | | | | |
| Revenue | Three Months | | |
| | | |
| (in millions) | 2022 | | 2021 | | | | | | |
| Market Intelligence | $ | 727 | | | $ | 524 | | | | | | | |
| Ratings | 868 | | | 1,017 | | | | | | | |
| Commodity Insights | 363 | | | 240 | | | | | | | |
| Mobility | 115 | | | — | | | | | | | |
| Indices | 322 | | | 270 | | | | | | | |
| | | | | | | | | |
| Engineering Solutions | 33 | | | — | | | | | | | |
Intersegment elimination 1 | (39) | | | (35) | | | | | | | |
| Total revenue | $ | 2,389 | | | $ | 2,016 | | | | | | | |
| | | | | | | | | | | | | | | | | |
| Operating Profit | Three Months | | |
| | | |
| (in millions) | 2022 | | 2021 | | | | | | |
Market Intelligence 2 | $ | 1,489 | | $ | 161 | | | | | | |
Ratings 3 | 511 | | 681 | | | | | | |
Commodity Insights 4 | 158 | | 134 | | | | | | |
Mobility 5 | 18 | | — | | | | | | |
Indices 6 | 224 | | 191 | | | | | | |
Engineering Solutions 7 | 1 | | | — | | | | | | | |
| | | | | | | | | |
| Total reportable segments | 2,401 | | 1,167 | | | | | | |
Corporate Unallocated expense 8 | (512) | | (86) | | | | | | |
Equity in Income on Unconsolidated Subsidiaries 9 | 3 | | | — | | | | | | | |
| Total operating profit | $ | 1,892 | | $ | 1,081 | | | | | | |
Note – In the first quarter of 2022, the Market Intelligence Commodities business was transferred to the Commodity Insights segment and prior-year amounts have been reclassified to conform with current presentation.
1Revenue for Ratings and expenses for Market Intelligence include an intersegment royalty charged to Market Intelligence for the rights to use and distribute content and data developed by Ratings.
2 2022 includes a gain on disposition of $1.3 billion, employee severance charges of $18 million and acquisition-related costs of $2 million. Operating profit for 2021 includes a gain on disposition of $2 million. Additionally, 2022 and 2021 includes amortization of intangibles from acquisitions of $64 million and $16 million, respectively.
3 2022 includes employee severance charges of $5 million. 2022 and 2021 also includes amortization of intangibles from acquisitions of $2 million and $5 million, respectively.
4 2022 includes employee severance costs of $7 million and acquisition-related costs of $2 million. 2022 and 2021 also includes amortization of intangibles from acquisitions of $13 million and $2 million, respectively.
5 2022 includes acquisition-related costs of $1 million and amortization of intangibles from acquisitions of $24 million.
6 2022 includes employee severance charges of $2 million. 2022 and 2021 includes amortization of intangibles from acquisitions of $4 million and $1 million, respectively.
7 2022 includes employee severance charges of $1 million and amortization of intangibles from acquisitions of $4 million.
8 Corporate Unallocated expense for 2022 includes IHS Markit merger costs of $230 million, a S&P Foundation grant of $200 million, employee severance charges of $46 million and acquisition-related costs of $15 million. 2021 includes IHS Markit merger costs of $49 million and Kensho retention related expense of $2 million. Additionally, Corporate Unallocated expense for both 2022 and 2021 includes amortization of intangibles from acquisitions of $15 million and $7 million, respectively.
9 Equity in Income on Unconsolidated Subsidiaries includes amortization of intangibles from acquisitions of $15 million.
The following table presents our revenue disaggregated by revenue type for the three months ended March 31:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Ratings | | Market Intelligence | | Commodity Insights | | Mobility | | Indices | | | | Engineering Solutions | | Intersegment Elimination 1 | | Total |
| | | | | | | | | | | | | | | | | |
| 2022 |
| Subscription | $ | — | | | $ | 659 | | | $ | 296 | | | $ | 86 | | | $ | 54 | | | | | $ | 30 | | | $ | — | | | $ | 1,125 | |
| Non-subscription / Transaction | 404 | | | 28 | | | 48 | | | 29 | | | — | | | | | 3 | | | — | | | 512 | |
| Non-transaction | 464 | | | — | | | — | | | — | | | — | | | | | — | | | (39) | | | 425 | |
| Asset-linked fees | — | | | — | | | — | | | — | | | 218 | | | | | — | | | — | | | 218 | |
| Sales usage-based royalties | — | | | — | | | 19 | | | — | | | 50 | | | | | — | | | — | | | 69 | |
| Recurring variable revenue | — | | | 40 | | | — | | | — | | | — | | | | | — | | | — | | | 40 | |
| Total revenue | $ | 868 | | | $ | 727 | | | $ | 363 | | | $ | 115 | | | $ | 322 | | | | | $ | 33 | | | $ | (39) | | | $ | 2,389 | |
| | | | | | | | | | | | | | | | | |
| Timing of revenue recognition | | | | | | | | | | | | | | | | | |
| Services transferred at a point in time | $ | 404 | | | $ | 28 | | | $ | 48 | | | $ | 29 | | | $ | — | | | | | $ | 3 | | | $ | — | | | $ | 512 | |
Services transferred over time | 464 | | | 699 | | | 315 | | | 86 | | | 322 | | | | | 30 | | | (39) | | | 1,877 | |
| Total revenue | $ | 868 | | | $ | 727 | | | $ | 363 | | | $ | 115 | | | $ | 322 | | | | | $ | 33 | | | $ | (39) | | | $ | 2,389 | |
| | | | | | | | | | | | | | | | | |
| |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Ratings | | Market Intelligence | | Commodity Insights | | Mobility | | Indices | | | | Engineering Solutions | | Intersegment Elimination 1 | | Total |
| | | | | | | | | | | | | | | | | |
| 2021 |
| Subscription | $ | — | | | $ | 512 | | | $ | 223 | | | $ | — | | | $ | 46 | | | | | $ | — | | | $ | — | | | $ | 781 | |
| Non-subscription / Transaction | 582 | | | 12 | | | 1 | | | — | | | — | | | | | — | | | — | | | 595 | |
| Non-transaction | 435 | | | — | | | — | | | — | | | — | | | | | — | | | (35) | | | 400 | |
| Asset-linked fees | — | | | — | | | — | | | — | | | 183 | | | | | — | | | — | | | 183 | |
| Sales usage-based royalties | — | | | — | | | 16 | | | — | | | 41 | | | | | — | | | — | | | 57 | |
| | | | | | | | | | | | | | | | | |
| Total revenue | $ | 1,017 | | | $ | 524 | | | $ | 240 | | | $ | — | | | $ | 270 | | | | | $ | — | | | $ | (35) | | | $ | 2,016 | |
| | | | | | | | | | | | | | | | | |
| Timing of revenue recognition | | | | | | | | | | | | | | | | | |
| Services transferred at a point in time | $ | 582 | | | $ | 12 | | | $ | 1 | | | $ | — | | | $ | — | | | | | $ | — | | | $ | — | | | $ | 595 | |
| Services transferred over time | 435 | | | 512 | | | 239 | | | — | | | 270 | | | | | — | | | (35) | | | 1,421 | |
| Total revenue | $ | 1,017 | | | $ | 524 | | | $ | 240 | | | $ | — | | | $ | 270 | | | | | $ | — | | | $ | (35) | | | $ | 2,016 | |
| | | | | | | | | | | | | | | | | |
| |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
1 Intersegment eliminations primarily consists of a royalty charged to Market Intelligence for the rights to use and distribute content and data developed by Ratings.
Note – In the first quarter of 2022, the Market Intelligence Commodities business was transferred to the Commodity Insights segment and prior-year amounts have been reclassified to conform with current presentation.
The following provides revenue by geographic region for the three months ended March 31:
| | | | | | | | | | | | | | | |
| | | |
| | | |
| (in millions) | 2022 | | 2021 | | | | |
| U.S. | $ | 1,426 | | | $ | 1,238 | | | | | |
| European region | 567 | | | 473 | | | | | |
| Asia | 264 | | | 208 | | | | | |
| Rest of the world | 132 | | | 97 | | | | | |
| Total | $ | 2,389 | | | $ | 2,016 | | | | | |
See Note 2 — Acquisitions and Divestitures and Note 10 — Restructuring for additional actions that impacted the segment operating results.
12. Commitments and Contingencies
Leases
We determine whether an arrangement meets the criteria for an operating lease or a finance lease at the inception of the arrangement. We have operating leases for office space and equipment. Our leases have remaining lease terms of 1 year to 11 years, some of which include options to extend the leases for up to 15 years, and some of which include options to terminate the leases within 1 year. We sublease certain real estate leases to third parties which mainly consist of operating leases for space within our offices.
Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expenses for these leases on a straight line-basis over the lease term in operating-related expenses and selling and general expenses.
Operating lease ROU assets and operating lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. Our future minimum based payments used to determine our lease liabilities include minimum based rent payments and escalations. As most of our leases do not provide an implicit rate, we use our estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The February 28, 2022 merger with IHS Markit resulted in an increase in ROU assets and operating lease liabilities of $230 million and $268 million, respectively.
During the three months ended March 31, 2022, we recorded a pre-tax impairment charge of $5 million related to the impairment and abandonment of operating lease related ROU assets. The impairment charges are included in selling and general expenses within the consolidated statements of income.
The following table provides information on the location and amounts of our leases on our consolidated balance sheets as of March 31, 2022 and December 31, 2021:
| | | | | | | | | | | | | | |
| | | | |
| (in millions) | | March 31, | | December 31, |
| Balance Sheet Location | | 2022 | | 2021 |
| Assets | | | | |
| Right of use assets | Lease right of use assets | $ | 625 | | | $ | 426 | |
| | | | |
| Liabilities | | | | |
| Other current liabilities | Current lease liabilities | 134 | | | 96 | |
| Lease liabilities — non-current | Non-current lease liabilities | 692 | | | 492 | |
| | | | |
The components of lease expense for the three months ended March 31 are as follows:
| | | | | | | | | | | | | | | | | |
| | | | | |
| (in millions) | 2022 | | 2021 | | | | | | |
| Operating lease cost | $ | 33 | | | $ | 33 | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| Sublease income | (1) | | | (1) | | | | | | | |
| Total lease cost | $ | 32 | | | $ | 32 | | | | | | | |
Supplemental information related to leases for the three months ended March 31 are as follows:
| | | | | | | | | | | | | | | | | | |
| | | | |
| (in millions) | | 2022 | | 2021 | | | | |
| Cash paid for amounts included in the measurement for operating lease liabilities | | | | | | | | |
| Operating cash flows for operating leases | | $ | 38 | | | $ | 32 | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Right of use assets obtained in exchange for lease obligations | | | | | | | | |
| Operating leases | | — | | | — | | | | | |
| | | | | | | | |
| | | | | | | | |
Weighted-average remaining lease term and discount rate for our operating leases are as follows:
| | | | | | | | | | | | |
| | March 31, | | December 31, |
| | 2022 | | 2021 |
| | | | |
| Weighted-average remaining lease term (years) | | 7.9 | | 8.3 |
| | | | |
| | | | |
| Weighted-average discount rate | | 3.36 | % | | 3.59 | % |
| | | | |
| | | | |
Maturities of lease liabilities for our operating leases are as follows: | | | | | | | | | |
| (in millions) | | | | | |
2022 (Excluding the three months ended March 31, 2022) | $ | 122 | | | | | |
| 2023 | 141 | | | | | |
| 2024 | 135 | | | | | |
| 2025 | 130 | | | | | |
| 2026 | 124 | | | | | |
| 2027 and beyond | 401 | | | | | |
| Total undiscounted lease payments | $ | 1,053 | | | | | |
| Less: Imputed interest | 227 | | | | | |
| Present value of lease liabilities | $ | 826 | | | | | |
Related Party Agreements
In June of 2012, we entered into a license agreement (the "License Agreement") with the holder of S&P Dow Jones Indices LLC noncontrolling interest, CME Group, replacing the 2005 license agreement between Indices and CME Group. Under the terms of the License Agreement, S&P Dow Jones Indices LLC receives a share of the profits from the trading and clearing of CME Group's equity index products. During the three months ended March 31, 2022 and 2021, S&P Dow Jones Indices LLC earned $41 million and $37 million, respectively, of revenue under the terms of the License Agreement. The entire amount of this revenue is included in our consolidated statement of income and the portion related to the 27% noncontrolling interest is removed in net income attributable to noncontrolling interests.
Legal and Regulatory Matters
In the normal course of business both in the United States and abroad, the Company and its subsidiaries are defendants in a number of legal proceedings and are often subjected to government and regulatory proceedings, investigations and inquiries.
S&P Global Ratings has been cooperating with an SEC investigation into possible violations of Section 15E of the Exchange Act and Rule 17g-5(c)(8) thereunder in connection with a 2017 credit rating analysis by S&P Global Ratings. S&P Global Ratings is currently in active discussions to resolve the SEC’s inquiry. S&P Global Ratings has not yet reached a definitive settlement agreement with the SEC on this matter but in the fourth quarter of 2021, accrued for potential monetary penalties based on discussions to date. While we cannot predict with certainty whether we will reach agreement, or the terms of any such agreement, at this time, we do not believe that the resolution of this matter will have a material adverse effect on our business, financial condition or results of operations.
A class action lawsuit was filed in Australia on August 7, 2020 against the Company and a subsidiary of the Company. A separate lawsuit was filed against the Company and a subsidiary of the Company in Australia on February 2, 2021 by two entities within the Basis Capital investment group. The lawsuits both relate to alleged investment losses in collateralized debt
obligations rated by Ratings prior to the financial crisis. We can provide no assurance that we will not be obligated to pay significant amounts in order to resolve these matters on terms deemed acceptable.
From time to time, the Company receives customer complaints, particularly, though not exclusively, in its Ratings and Indices segments. The Company believes it has strong contractual protections in the terms and conditions included in its arrangements with customers. Nonetheless, in the interest of managing customer relationships, the Company from time to time engages in dialogue with such customers in an effort to resolve such complaints, and if such complaints cannot be resolved through dialogue, may face litigation regarding such complaints. The Company does not expect to incur material losses as a result of these matters.
Moreover, various government and self-regulatory agencies frequently make inquiries and conduct investigations into our compliance with applicable laws and regulations, including those related to ratings activities and antitrust matters. For example, as a nationally recognized statistical rating organization registered with the SEC under Section 15E of the Exchange Act, S&P Global Ratings is in ongoing communication with the staff of the SEC regarding compliance with its extensive obligations under the federal securities laws. Although S&P Global seeks to promptly address any compliance issues that it detects or that the staff of the SEC or another regulator raises, there can be no assurance that the SEC or another regulator will not seek remedies against S&P Global for one or more compliance deficiencies. Any of these proceedings, investigations or inquiries could ultimately result in adverse judgments, damages, fines, penalties or activity restrictions, which could adversely impact our consolidated financial condition, cash flows, business or competitive position.
In view of the uncertainty inherent in litigation and government and regulatory enforcement matters, we cannot predict the eventual outcome of such matters or the timing of their resolution, or in most cases reasonably estimate what the eventual judgments, damages, fines, penalties or impact of activity (if any) restrictions may be. As a result, we cannot provide assurance that such outcomes will not have a material adverse effect on our consolidated financial condition, cash flows, business or competitive position. As litigation or the process to resolve pending matters progresses, as the case may be, we will continue to review the latest information available and assess our ability to predict the outcome of such matters and the effects, if any, on our consolidated financial condition, cash flows, business or competitive position, which may require that we record liabilities in the consolidated financial statements in future periods.
13. Recently Issued or Adopted Accounting Standards
In October of 2021, the Financial Accounting Standards Board ("FASB") issued guidance that amends the acquirer's accounting for contract assets and contract liabilities from contracts with customers in a business combination in accordance with Topic 606. The guidance is effective for reporting periods beginning after December 15, 2022, early adoption is permitted. We early adopted this guidance on January 1, 2022. The early adoption of this standard applied to the acquired unearned revenue and contract costs associated with the IHS Markit merger. The adoption did not have a significant impact on our consolidated financial statements.
In March of 2020, the FASB issued accounting guidance to provide temporary optional expedients and exceptions to the current contract modifications and hedge accounting guidance in light of the expected market transition from London Interbank Offered Rate ("LIBOR") to alternative rates. The new guidance provides optional expedients and exceptions to transactions affected by reference rate reform if certain criteria are met. The transactions primarily include (1) contract modifications, (2) hedging relationships, and (3) sale or transfer of debt securities classified as held-to-maturity. The Company may elect to adopt the amendments prospectively to transactions existing as of or entered into from the date of adoption through December 31, 2022. We do not expect this guidance to have a significant impact on our consolidated financial statements.